title: LRRK2 G2385R modulates age at onset in Parkinson's disease: A multi-center pooled analysis.
authors.forename: E K
authors.initials: EK
authors.lastname: Tan
authors.forename: R
authors.initials: R
authors.lastname: Peng
authors.forename: Y R
authors.initials: YR
authors.lastname: Wu
authors.forename: R M
authors.initials: RM
authors.lastname: Wu
authors.forename: Y H
authors.initials: YH
authors.lastname: Wu-Chou
authors.forename: L C
authors.initials: LC
authors.lastname: Tan
authors.forename: X K
authors.initials: XK
authors.lastname: An
authors.forename: C M
authors.initials: CM
authors.lastname: Chen
authors.forename: S
authors.initials: S
authors.lastname: Fook-Chong
authors.forename: C S
authors.initials: CS
authors.lastname: Lu
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D019943:Amino Acid Substitution / Q000235:genetics*; D005260:Female; D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000453:epidemiology* / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D013624:Taiwan / Q000453:epidemiology
chemical_list: C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases